Jérémy Vuilleumier studied at the University of Fribourg and graduated with a Bachelor of Science in Chemistry in 2013. He then joined the Ecole Polytechnique Fédérale de Lausanne (EPFL) where he received his Master's degree in Chemical and Biological Chemistry in 2015. Jérémy completed his Ph.D in the Laboratory of Functional Biomaterials at EPFL. During his thesis, he focused on the design and development of nanoparticles with light-sensitive molecules to selectively release anti-cancer drugs inside tumor cells. Jérémy joined iPrint to develop a microfluidic device for staining bacteria.